EP1919449A2 - Kit et composition antibiotiques et leurs utilisations - Google Patents

Kit et composition antibiotiques et leurs utilisations

Info

Publication number
EP1919449A2
EP1919449A2 EP06847249A EP06847249A EP1919449A2 EP 1919449 A2 EP1919449 A2 EP 1919449A2 EP 06847249 A EP06847249 A EP 06847249A EP 06847249 A EP06847249 A EP 06847249A EP 1919449 A2 EP1919449 A2 EP 1919449A2
Authority
EP
European Patent Office
Prior art keywords
agent
acid
antibiotic
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06847249A
Other languages
German (de)
English (en)
Inventor
Doron Friedman
Alex Besonov
Dov Tamarkin
Meir Eini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Foamix Ltd
Original Assignee
Foamix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Foamix Ltd filed Critical Foamix Ltd
Publication of EP1919449A2 publication Critical patent/EP1919449A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention concerne un kit thérapeutique destiné à délivrer une dose sans danger et efficace d'un agent antibiotique, y compris un conditionnement pour aérosol. Ledit kit inclut un récipient contenant un produit sous pression et un orifice de sortie capable de libérer le produit sous pression sous la forme d'une mousse. Ledit produit sous pression comprend une composition moussante qui inclut : un agent antibiotique; au moins un support organique choisi dans le groupe comprenant un support organique hydrophobe, un solvant polaire organique, un émollient et leurs mélanges, à une concentration comprise entre environ 2 % et environ 50 % en poids, un agent tensioactif, d'environ 0.01 % à environ 5 % en poids d'au moins un additif polymère choisi dans le groupe comprenant un agent bioadhésif, un agent gélifiant, un agent filmogène et un agent de changement de phase, de l'eau; et un gaz propulseur liquéfié ou compressé à une concentration comprise entre environ 3 % et environ 25 % en poids de la composition totale.
EP06847249A 2005-06-07 2006-06-07 Kit et composition antibiotiques et leurs utilisations Withdrawn EP1919449A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68824405P 2005-06-07 2005-06-07
PCT/IB2006/003975 WO2007099396A2 (fr) 2005-06-07 2006-06-07 Kit et composition antibiotiques et leurs utilisations

Publications (1)

Publication Number Publication Date
EP1919449A2 true EP1919449A2 (fr) 2008-05-14

Family

ID=38459394

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06847249A Withdrawn EP1919449A2 (fr) 2005-06-07 2006-06-07 Kit et composition antibiotiques et leurs utilisations

Country Status (4)

Country Link
EP (1) EP1919449A2 (fr)
AU (1) AU2006339311A1 (fr)
CA (1) CA2611577A1 (fr)
WO (1) WO2007099396A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US9724353B2 (en) 2011-09-09 2017-08-08 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
MXPA05004278A (es) 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
WO2008075207A2 (fr) * 2006-04-04 2008-06-26 Foamix Ltd. Composition expansible d'augmentation anti-infectieuse, et kits et utilisations de celle-ci
EP2029106A2 (fr) * 2006-06-07 2009-03-04 Foamix Ltd. Vecteur expansible à base de polypropylène glycol et compositions pharmaceutiques associées
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
MX2009011938A (es) * 2007-05-04 2009-11-13 Procter & Gamble Composiciones antimicrobianas, productos y metodos de uso.
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (fr) 2007-11-30 2009-06-04 Foamix Ltd. Peroxyde de benzoyle contenant de la mousse
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
WO2010041141A2 (fr) 2008-10-07 2010-04-15 Foamix Ltd. Support expansible à base d’huile et préparations
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2009103069A1 (fr) * 2008-02-15 2009-08-20 Osborne David W Système d’accentuation de la pénétration de la peau pour médicaments polaires
EP2273989A4 (fr) 2008-04-07 2013-05-01 Interface Biologics Inc Polythérapie pour le traitement des infections bactériennes
EP2174650A1 (fr) * 2008-10-08 2010-04-14 Polichem SA Émulsions à libération modifiée pour une application sur la peau ou la muqueuse vaginale
FR2943914A1 (fr) * 2009-04-06 2010-10-08 Fabre Pierre Dermo Cosmetique Flacon mousseur comprenant une composition pharmaceutique
CA2760186C (fr) 2009-04-28 2019-10-29 Foamix Ltd. Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
WO2011013009A2 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses légères, et leurs utilisations
WO2011039638A2 (fr) 2009-10-02 2011-04-07 Foamix Ltd. Compositions de tétracycline à usage topique
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011061155A1 (fr) * 2009-11-17 2011-05-26 Bayer Consumer Care Ag Formulations antifongiques et leur utilisation
CN108785654A (zh) 2009-11-23 2018-11-13 丘比斯特制药有限责任公司 脂肽组合物和相关方法
CA3054236A1 (fr) 2011-06-28 2013-01-03 Chemo Research Sl Formulations de gel a base de metronidazole aqueux mucoadhesif a dosage eleve et leur utilisation pour traiter une vaginose bacterienne
WO2013042122A1 (fr) 2011-09-21 2013-03-28 Cohen Irun R Composés de bêta-lactame pour augmenter les réponses immunitaires médiées par les lymphocytes t
AU2012311050A1 (en) 2011-09-21 2014-03-06 Stem Cell Medicine Ltd. Beta-lactam compounds for treating diabetes
SG190466A1 (en) * 2011-11-18 2013-06-28 Agency Science Tech & Res Methods for diagnosis and/or prognosis of ovarian cancer
CN102526398A (zh) * 2012-01-17 2012-07-04 肖文辉 一种治疗慢性盆腔炎的中药外用制剂
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
AU2014227660B2 (en) 2013-03-15 2014-11-06 Merck Sharp & Dohme Llc Ceftolozane antibiotic compositions
WO2015035376A2 (fr) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Traitement d'infections au moyen de ceftolozane/tazobactam chez des sujets ayant une fonction rénale altérée
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
GB201415776D0 (en) 2014-09-05 2014-10-22 Singh Ishwar And Taylor Edward New antibacterial products
ES2846882T3 (es) 2015-03-23 2021-07-30 Biopharmx Inc Composición farmacéutica de tetraciclina para uso dermatológico
WO2017009870A1 (fr) * 2015-07-13 2017-01-19 Ahir Pramodbhai N Formulation topique pour maladie chronique de la peau et des cheveux
CN105726545A (zh) * 2016-03-22 2016-07-06 史飞 头孢拉定通过抑制t-lak细胞起源的蛋白激酶(topk)预防和/或治疗topk活性异常增高的皮肤炎症
CN106045875A (zh) * 2016-06-25 2016-10-26 仇颖超 一种盐酸土霉素的制备方法
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
EP3585381A4 (fr) 2017-02-24 2020-08-19 The Regents of The University of California Compositions et méthodes favorisant la croissance des cheveux au moyen d'inhibiteurs de mpc1
CN110944634A (zh) 2017-06-30 2020-03-31 加利福尼亚大学董事会 用于调节毛发生长的组合物和方法
MX2020002389A (es) * 2017-09-29 2020-10-01 Univ California Composiciones y metodos para modular el crecimiento del cabello.
CN111920812B (zh) * 2020-07-10 2022-09-20 深圳市臻质医疗科技有限公司 一种钙通道抑制剂氧海罂粟碱在骨关节炎中的应用
CN114632075B (zh) * 2022-05-19 2022-07-15 奥信阳光(北京)药业科技有限公司 一种伏立康唑雾化吸入剂和用途
CN115463091B (zh) * 2022-10-27 2023-04-07 新基元(北京)医药科技有限公司 一种改善稳定性的米诺环素泡沫剂
CN115739051A (zh) * 2022-11-30 2023-03-07 浙江工业大学 一种疏水膜及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05004278A (es) * 2002-10-25 2005-10-05 Foamix Ltd Espuma cosmetica y farmaceutica.
EP1592420B1 (fr) * 2003-01-24 2014-01-01 Stiefel Research Australia Pty Ltd Mousse de phosphate de clindamycine
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
AU2004261063A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
EP2977043A3 (fr) * 2003-08-25 2016-04-06 Foamix Pharmaceuticals Ltd. Mousse pharmaceutique pénétrante

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007099396A2 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9724353B2 (en) 2011-09-09 2017-08-08 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
US10028963B2 (en) 2011-09-09 2018-07-24 Merck Sharp & Dohme Corp. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US8685957B1 (en) 2012-09-27 2014-04-01 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions

Also Published As

Publication number Publication date
WO2007099396A2 (fr) 2007-09-07
AU2006339311A1 (en) 2007-09-07
WO2007099396A3 (fr) 2008-03-13
CA2611577A1 (fr) 2007-09-07
AU2006339311A2 (en) 2007-09-07

Similar Documents

Publication Publication Date Title
US20190076451A1 (en) Antibiotic Kit and Composition and Uses Thereof
US9211259B2 (en) Antibiotic kit and composition and uses thereof
EP1919449A2 (fr) Kit et composition antibiotiques et leurs utilisations
US20190022000A1 (en) Anti-infection augmentation foamable compositions and kit and uses thereof
WO2008075207A2 (fr) Composition expansible d'augmentation anti-infectieuse, et kits et utilisations de celle-ci
US10588858B2 (en) Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US7645803B2 (en) Saccharide foamable compositions
US8343945B2 (en) Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20190307685A1 (en) Nonsteroidal immunomodulating kit and composition and uses thereof
US20140182585A1 (en) Aerosol container for foamable compositions
US20070292461A1 (en) Oleaginous pharmaceutical and cosmetic foam
US20080206161A1 (en) Quiescent foamable compositions, steroids, kits and uses thereof
US20090130029A1 (en) Glycerol ethers vehicle and pharmaceutical compositions thereof
MX2007014106A (es) Composiciones espumables de sacarido

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20090922

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120102